A network for advancing cancer treatment through clinical trials
Rochester Network Lead Academic Participating Site
This study is all about finding better treatments for cancer, and it invites cancer patients to join exciting clinical trials that could offer them access to new therapies that might improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10795939 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment by serving as a Lead Academic Site for the National Cancer Institute's National Clinical Trials Network (NCTN). The University of Rochester's Wilmot Cancer Institute collaborates with multidisciplinary teams to conduct late-phase clinical trials, aiming to develop and evaluate novel therapeutic strategies for cancer patients. By leveraging extensive tissue banking and correlative studies, the program seeks to improve patient outcomes through innovative cancer therapies. Patients may have the opportunity to participate in cutting-edge clinical trials that could lead to new treatment options.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with various types of cancer who are seeking advanced treatment options through clinical trials.
Not a fit: Patients with early-stage cancer or those who are not eligible for clinical trials may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with access to novel cancer therapies that may improve treatment outcomes.
How similar studies have performed: Previous research within the NCTN framework has shown success in developing effective cancer treatments, indicating that this approach is both tested and promising.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Barr, Paul M — University of Rochester
- Study coordinator: Barr, Paul M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.